Literature DB >> 25967124

Long-Term Neurodevelopmental Outcome of Children Treated with Tri-Iodothyronine after Cardiac Surgery: Follow-Up of a Double-Blind, Randomized, Placebo-Controlled Study.

Janna Mittnacht1, Daniela Choukair, Carolin Kneppo, Romuald Brunner, Peter Parzer, Matthias Gorenflo, Markus Bettendorf.   

Abstract

BACKGROUND: Transient thyroid dysfunction occurs in children after cardiopulmonary bypass (CPB). We demonstrated significant benefits of acute postoperative tri-iodothyronine (T3) treatment for recovery and myocardial function. Now we report the long-term neurodevelopment of these children.
METHODS: Twenty-eight children (70% of the original study population) could be recruited for a follow-up examination (median age 10.7 years, range 10-19.6 years) retaining the double-blind, randomized, placebo-controlled protocol. Cognitive function and motor development were tested, as were growth and thyroid and cardiac functions.
RESULTS: The median full-scale intelligence quotient of all children was within the reference range and similar in the placebo and T3 groups. Tests for motor and cognitive functions, growth, and thyroid and cardiac functions revealed concurrent results.
CONCLUSIONS: Overall intellectual development is preserved in adolescents treated with CPB in infancy irrespectively of low postoperative thyroid hormone concentrations. While acute postoperative T3 treatment in children after CPB improves recovery, no significant long-term effects on neurodevelopment could be detected. We therefore speculate that transient postoperative thyroid dysfunction by means of nonthyroidal illness syndrome is predominantly mediated by extranuclear, nongenomic mechanisms and thus acutely affects the cardiovascular system but not the development of the central nervous system mediated by genomic mechanisms.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25967124     DOI: 10.1159/000381711

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  4 in total

1.  Changes in thyroid hormone concentrations during neonatal extracorporeal membrane oxygenation.

Authors:  L Leeuwen; A F J van Heijst; J van Rosmalen; Y B de Rijke; L W J E Beurskens; D Tibboel; E L T van den Akker; H IJsselstijn
Journal:  J Perinatol       Date:  2017-04-27       Impact factor: 2.521

2.  Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management.

Authors:  An Jacobs; Inge Derese; Sarah Vander Perre; Esther van Puffelen; Sören Verstraete; Lies Pauwels; Sascha Verbruggen; Pieter Wouters; Lies Langouche; Gonzalo Garcia Guerra; Koen Joosten; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  Thyroid       Date:  2019-03-11       Impact factor: 6.568

3.  What's new in the long-term neurodevelopmental outcome of critically ill children.

Authors:  S Verstraete; G Van den Berghe; I Vanhorebeek
Journal:  Intensive Care Med       Date:  2017-10-23       Impact factor: 17.440

Review 4.  The Current Status of Neuroprotection in Congenital Heart Disease.

Authors:  Kei Kobayashi; Christopher Liu; Richard A Jonas; Nobuyuki Ishibashi
Journal:  Children (Basel)       Date:  2021-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.